CTL quality and the control of human retroviral infections

European Journal of Immunology

Volumn 39, Issue 7, 2009, Pages 1700-1712

  Bangham, Charles R M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

CTL efficiency; Functional avidity; HIV 1; HTLV 1; Polyfunctionality

Indexed keywords

ANTIRETROVIRUS AGENT; CD8 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 15; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; TRANSCRIPTION FACTOR FOXP3;

BINDING AFFINITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FEEDBACK SYSTEM; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOSTIMULATION; INFECTION CONTROL; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MATHEMATICAL MODEL; MOLECULAR MECHANICS; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; RELIABILITY; REVIEW; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS REPLICATION;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; GENES, MHC CLASS I; GENOTYPE; HIV INFECTIONS; HTLV-I INFECTIONS; HUMANS; RETROVIRIDAE INFECTIONS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 69249108828     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939451     Document Type: Review

References (153)

1. Blanden, R. V., T cell response to viral and bacterial infection. Transplant. Rev. 1974. 19: 56-88.
2. Zinkernagel, R. M. and Doherty, P. C., Restriction of in vitro T cellmediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 1974. 248: 701-702.
3. Zinkernagel, R. M. and Doherty, P. C., MHC-restricted cytotoxic T cells: Studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv. Immunol. 1979. 27: 51-177.
4. McMichael, A. J., Principles of immunology. In Warrell, D. A., Cox, T. M., Firth, J. D. and Benz, E. J. (Ed.) Oxford Textbook of Medicine, Fourth Edn. Oxford University Press, Oxford 2003, pp 131-144.
5. Blankson, J. N. and Siliciano, R. F., Elite suppression of HIV-1 replication. Immunity 2008. 29: 845-847.
6. Rouzioux, C., Hubert, J. B., Burgard, M., Deveau, C., Goujard, C., Bary, M., Sereni, D. et al., Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+T cell counts. J. Infect. Dis. 2005. 192: 46-55.
7. Bangham, C. R. M., Human T-lymphotropic virus type 1 (HTLV-1)associated diseases. In: R. A. Kaslow, J. M. M. A. V. S. Hill. (Ed.) Genetic Susceptibility to Infectious Diseases. Oxford University Press, Oxford UK 2008, pp 303-317.
8. Carrington, M. and O'Brien, S. J., The influence of HLA genotype on AIDS. Annu. Rev. Med. 2003. 54: 535-551.
9. Borrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M. and Oldstone, M. B., Virus-specific CD8+cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 1994. 68: 6103-6110.
10. Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C. and Ho, D. D., Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 1994. 68: 4650-4655.
11. Geels, M. J., Jansen, C. A., Baan, E., De Cuyper, I. M., van Schijndel, G. J., Schuitemaker, H., Goudsmit, J. et al., CTL escape and increased viremia irrespective of HIV-specific CD4+T-helper responses in two HIV-infected individuals. Virology 2006. 345: 209-219.
12. Goulder, P. J., Phillips, R. E., Colbert, R. A., McAdam, S., Ogg, G., Nowak, M. A., Giangrande, P. et al., Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 1997. 3: 212-217.
13. Karlsson, A. C., Iversen, A. K., Chapman, J. M., de Oliviera, T., Spotts, G., McMichael, A. J., Davenport, M. P. et al., Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape. PLoS ONE 2007. 2: E225.
14. Phillips, R. E., Rowland-Jones, S., Nixon, D. F., Gotch, F. M., Edwards, J. P., Ogunlesi, A. O., Elvin, J. G. et al., Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991. 354: 453-459.
15. Leslie, A., Kavanagh, D., Honeyborne, I., Pfafferott, K., Edwards, C., Pillay, T., Hilton, L. et al., Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. J. Exp. Med. 2005. 201: 891-902.
16. Leslie, A. J., Pfafferott, K. J., Chetty, P., Draenert, R., Addo, M. M., Feeney, M., Tang, Y. et al., HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 2004. 10: 282-289.
17. Niewiesk, S., Daenke, S., Parker, C. E., Taylor, G., Weber, J., Nightingale, S. and Bangham, C. R., The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J. Virol. 1994. 68: 6778-6781.
18. Price, D. A., Goulder, P. J., Klenerman, P., Sewell, A. K., Easterbrook, P. J., Troop, M., Bangham, C. R. and Phillips, R. E., Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. USA 1997. 94: 1890-1895.
19. Oxenius, A., Price, D. A., Trkola, A., Edwards, C., Gostick, E., Zhang, H. T., Easterbrook, P. J. et al., Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+T cell responses and decrease in HIV-1-specific CD4+ and CD8+T cell frequencies. J. Infect. Dis. 2004. 190: 713-721.
20. Jin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C. E. et al., Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 1999. 189: 991-998.
21. Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G., Simon, M. A., Lifton, M. A., Racz, P. et al., Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999. 283: 857-860.
22. Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P. et al., Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998. 279: 2103-2106.
23. Schellens, I. M., Borghans, J. A., Jansen, C. A., De Cuyper, I. M., Geskus, R. B., van Baarle, D. and Miedema, F., Abundance of early functional HIV-specific CD8+T cells does not predict AIDS-free survival time. PLoS ONE 2008. 3: E2745.
24. Asquith, B. and Bangham, C. R., Quantifying HTLV-I dynamics. Immunol. Cell Biol. 2007. 85: 280-286.
25. Ogg, G. S., Jin, X., Bonhoeffer, S., Moss, P., Nowak, M. A., Monard, S., Segal, J. P. et al., Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J. Virol. 1999. 73: 797-800.
26. Kalams, S. A., Goulder, P. J., Shea, A. K., Jones, N. G., Trocha, A. K., Ogg, G. S. and Walker, B. D., Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. J. Virol. 1999. 73: 6721-6728.
27. Casazza, J. P., Betts, M. R., Picker, L. J. and Koup, R. A., Decay kinetics of human immunodeficiency virus-specific CD8+T cells in peripheral blood after initiation of highly active antiretroviral therapy. J. Virol. 2001. 75: 6508-6516.
28. Cao, J., McNevin, J., Malhotra, U. and McElrath, M. J., Evolution of CD8+T cell immunity and viral escape following acute HIV-1 infection. J. Immunol. 2003. 171: 3837-3846.
29. Kubota, R., Hanada, K., Furukawa, Y., Arimura, K., Osame, M., Gojobori, T. and Izumo, S., Genetic stability of human T lymphotropic virus type I despite antiviral pressures by CTLs. J. Immunol. 2007. 178: 5966-5972.
30. Niewiesk, S., Daenke, S., Parker, C. E., Taylor, G., Weber, J., Nightingale, S. and Bangham, C. R., Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J. Virol. 1995. 69: 2649-2653.
31. Jeffery, K. J., Siddiqui, A. A., Bunce, M., Lloyd, A. L., Vine, A. M., Witkover, A. D., Izumo, S. et al., The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J. Immunol. 2000. 165: 7278-7284.
32. Jeffery, K. J., Usuku, K., Hall, S. E., Matsumoto, W., Taylor, G. P., Procter, J., Bunce, M. et al., HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc. Natl. Acad. Sci. USA 1999. 96: 3848-3853.
33. Vine, A. M., Witkover, A. D., Lloyd, A. L., Jeffery, K. J., Siddiqui, A., Marshall, S. E., Bunce, M. et al., Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. J. Infect. Dis. 2002. 186: 932-939.
34. Vine, A. M., Heaps, A. G., Kaftantzi, L., Mosley, A., Asquith, B., Witkover, A., Thompson, G. et al., The role of CTLs in persistent viral infection: Cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1. J. Immunol. 2004. 173: 5121-5129.
35. Bangham, C. R. M., Kermode, A. G., Hall, S. E. and Daenke, S., The cytotoxic T-lymphocyte response to HTLV-I: The main determinant of disease? Semin. Virol. 1996. 7: 41-48.
36. Parker, C. E., Daenke, S., Nightingale, S. and Bangham, C. R., Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 1992. 188: 628-636.
37. Parker, C. E., Nightingale, S., Taylor, G. P., Weber, J. and Bangham, C. R., Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J. Virol. 1994. 68: 2860-2868.
38. Kubota, R., Nagai, M., Kawanishi, T., Osame, M. and Jacobson, S., Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: Correlation with HTLV type 1 proviral load. AIDS Res. Hum. Retroviruses 2000. 16: 1705-1709.
39. Wodarz, D., Hall, S. E., Usuku, K., Osame, M., Ogg, G. S., McMichael, A. J., Nowak, M. A. and Bangham, C. R., Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1. Proc. R. Soc. Lond., B, Biol. Sci. 2001. 268: 1215-1221.
40. Nowak, M. A. and Bangham, C. R., Population dynamics of immune responses to persistent viruses. Science 1996. 272: 74-79.
41. Betts, M. R., Ambrozak, D. R., Douek, D. C., Bonhoeffer, S., Brenchley, J.M., Casazza, J. P., Koup, R. A. and Picker, L. J., Analysis of total human immunodeficiency virus (HIV)-specific CD4(1) and CD8(1) T-cell responses: Relationship to viral load in untreated HIV infection. J. Virol. 2001. 75: 11983-11991.
42. Zafiropoulos, A., Barnes, E., Piggott, C. and Klenerman, P., Analysis of 'driver' and 'passenger' CD81T-cell responses against variable viruses. Proc. Biol. Sci. 2004. 271: S53-S56.
43. Zuniga, R., Lucchetti, A., Galvan, P., Sanchez, S., Sanchez, C., Hernandez, A., Sanchez, H. et al., Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J. Virol. 2006. 80: 3122-3125.
44. Asquith, B. and Bangham, C. R., How does HTLV-I persist despite a strong cell-mediated immune response? Trends Immunol. 2008. 29: 4-11.
45. Daucher, M., Price, D. A., Brenchley, J. M., Lamoreaux, L., Metcalf, J. A., Rehm, C., Nies-Kraske, E. et al., Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD81T cells. J. Virol. 2008. 82: 4102-4114.
46. Addo, M. M., Yu, X. G., Rathod, A., Cohen, D., Eldridge, R. L., Strick, D., Johnston, M. N. et al., Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 2003. 77: 2081-2092.
47. Regoes, R. R., Yates, A. and Antia, R., Mathematical models of cytotoxic T-lymphocyte killing. Immunol. Cell Biol. 2007. 85: 274-279.
48. Hanon, E., Hall, S., Taylor, G. P., Saito, M., Davis, R., Tanaka, Y., Usuku, K. et al., Abundant tax protein expression in CD41T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000. 95: 1386-1392.
49. Asquith, B., Mosley, A. J., Barfield, A., Marshall, S. E., Heaps, A., Goon, P., Hanon, E. et al., A functional CD8+cell assay reveals individual variation in CD8+cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J. Gen. Virol. 2005. 86: 1515-1523.
50. Kattan, T., MacNamara, A., Rowan, A., Nose, H., Mosley, A. J., Tanaka, Y., Taylor, G. P. et al., The avidity and lytic efficiency of the CTL response to HTLV-1. J. Immunol. 2009. 182: 5723-5729.
51. Asquith, B., Zhang, Y., Mosley, A. J., de Lara, C. M., Wallace, D. L., Worth, A., Kaftantzi, L. et al., In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc. Natl. Acad. Sci. USA 2007. 104: 8035-8040.
52. Betts, M. R., Brenchley, J. M., Price, D. A., De Rosa, S. C., Douek, D. C., Roederer, M. and Koup, R. A., Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 2003. 281: 65-78.
53. Sabouri, A. H., Usuku, K., Hayashi, D., Izumo, S., Ohara, Y., Osame, M. and Saito, M., Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+T cells in HTLV-1-associated neurologic disease. Blood 2008. 112: 2411-2420.
54. Nagai, M., Usuku, K., Matsumoto, W., Kodama, D., Takenouchi, N., Moritoyo, T., Hashiguchi, S. et al., Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: High proviral load strongly predisposes to HAM/TSP. J. Neurovirol. 1998. 4: 586-593.
55. Yamano, Y., Nagai, M., Brennan, M., Mora, C. A., Soldan, S. S., Tomaru, U., Takenouchi, N. et al., Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(1) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 2002. 99: 88-94.
56. Asquith, B., Edwards, C. T., Lipsitch, M. and McLean, A. R., Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol. 2006. 4: E90.
57. Asquith, B. and McLean, A. R., In vivo CD8+T cell control of immunodeficiency virus infection in humans and macaques. Proc. Natl. Acad. Sci. USA 2007. 104: 6365-6370.
58. Ahearne, P. M., Morgan, R. A., Sebastian, M. W., Bolognesi, D. P. and Weinhold, K. J., Multiple CTL specificities against autologous HIV-1-infected BLCLs. Cell. Immunol. 1995. 161: 34-41.
59. Buseyne, F., Fevrier, M., Garcia, S., Gougeon, M. L. and Riviere, Y., Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: Inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+cells. Virology 1996. 225: 248-253.
60. McElrath, M. J., Rabin, M., Hoffman, M., Klucking, S., Garcia, J. V. and Greenberg, P. D., Evaluation of human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte responses utilizing B-lymphoblastoid cell lines transduced with the CD4 gene and infected with HIV-1. J. Virol. 1994. 68: 5074-5083.
61. Shankar, P., Sprang, H. and Lieberman, J., Effective lysis of HIV-1-infected primary CD4+T cells by a cytotoxic T-lymphocyte clone directed against a novel A2-restricted reverse-transcriptase epitope. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1998. 19: 111-120.
62. Tomiyama, H., Akari, H., Adachi, A. and Takiguchi, M., Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production. J. Virol. 2002. 76: 7535-7543.
63. Yang, O. O., Kalams, S. A., Rosenzweig, M., Trocha, A., Jones, N., Koziel, M., Walker, B. D. and Johnson, R. P., Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J. Virol. 1996. 70: 5799-5806.
64. Yang, O. O., Kalams, S. A., Trocha, A., Cao, H., Luster, A., Johnson, R. P. and Walker, B. D., Suppression of human immunodeficiency virus type 1 replication by CD8+cells: Evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 1997. 71: 3120-3128.
65. Yang, O. O., Assessing the antiviral activity of HIV-1-specific cytotoxic T lymphocytes. Methods Mol. Biol. 2009. 485: 407-415.
66. Migueles, S. A., Osborne, C. M., Royce, C., Compton, A. A., Joshi, R. P., Weeks, K. A., Rood, J. E. et al., Lytic granule loading of CD8+T cells is required for HIV-infected cell elimination associated with immune control. Immunity 2008. 29: 1009-1021.
67. Alexander-Miller, M. A., Leggatt, G. R. and Berzofsky, J. A., Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl. Acad. Sci. USA 1996. 93: 4102-4107.
68. Busch, D. H. and Pamer, E. G., T cell affinity maturation by selective expansion during infection. J. Exp. Med. 1999. 189: 701-710.
69. Savage, P. A., Boniface, J. J. and Davis, M. M., A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 1999. 10: 485-492.
70. Price, D. A., Brenchley, J.M., Ruff, L. E., Betts,M. R., Hill, B. J., Roederer, M., Koup, R. A. et al., Avidity for antigen shapes clonal dominance in CD81 T cell populations specific for persistent DNA viruses. J. Exp. Med. 2005. 202: 1349-1361.
71. Bihl, F., Frahm, N., Di Giammarino, L., Sidney, J., John, M., Yusim, K., Woodberry, T. et al., Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. J. Immunol. 2006. 176: 4094-4101.
72. Dzutsev, A. H., Belyakov, I. M., Isakov, D. V., Margulies, D. H. and Berzofsky, J. A., Avidity of CD8 T cells sharpens immunodominance. Int. Immunol. 2007. 19: 497-507.
73. Derby, M., Alexander-Miller, M., Tse, R. and Berzofsky, J., High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J. Immunol. 2001. 166: 1690-1697.
74. Valitutti, S., Muller, S., Dessing, M. and Lanzavecchia, A., Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 1996. 183: 1917-1921.
75. Wiedemann, A., Depoil, D., Faroudi, M. and Valitutti, S., Cytotoxic T lymphocytes kill multiple targets simultaneously via spatiotemporal uncoupling of lytic and stimulatory synapses. Proc. Natl. Acad. Sci. USA 2006. 103: 10985-10990.
76. Almeida, J. R., Price, D. A., Papagno, L., Arkoub, Z. A., Sauce, D., Bornstein, E., Asher, T. E. et al., Superior control of HIV-1 replication by CD81T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 2007. 204: 2473-2485.
77. Bennett, M. S., Ng, H. L., Dagarag, M., Ali, A. and Yang, O. O., Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells. J. Virol. 2007. 81: 4973-4980.
78. Chen, H., Piechocka-Trocha, A., Miura, T., Brockman, M. A., Julg, B. D., Baker, B. M., Rothchild, A. C. et al., Differential neutralization of HIV replication in autologous CD4 T cells by HIV-specific CTL. J. Virol. 2009. 83: 3138-3149.
79. Speiser, D. E., Kyburz, D., Stubi, U., Hengartner, H. and Zinkernagel, R. M., Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection. J. Immunol. 1992. 149: 972-980.
80. Alexander-Miller, M. A., High-avidity CD8+T cells: Optimal soldiers in the war against viruses and tumors. Immunol. Res. 2005. 31: 13-24.
81. Kuball, J., Hauptrock, B., Malina, V., Antunes, E., Voss, R. H., Wolfl, M., Strong, R. et al., Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domain. J. Exp. Med. 2009. 206: 463-475.
82. Zehn, D., Lee, S. Y. and Bevan, M. J., Complete but curtailed T-cell response to very low-affinity antigen. Nature 2009. 458: 211-214.
83. Shaw, S., Goldstein, G., Springer, T. A. and Biddison, W. E., Susceptibility of cytotoxic T lymphocyte (CTL) clones to inhibition by anti-T3 and anti-T4 (but not anti-LFA-1) monoclonal antibodies varies with the "avidity" of CTL-target interaction. J. Immunol. 1985. 134: 3019-3026.
84. Spits, H., Yssel, H., Voordouw, A. and de Vries, J. E., The role of T8 in the cytotoxic activity of cloned cytotoxic T lymphocyte lines specific for class II and class I major histocompatibility complex antigens. J. Immunol. 1985. 134: 2294-2298.
85. de Vries, J. E., Yssel, H. and Spits, H., Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes. Immunol. Rev. 1989. 109: 119-141.
86. Lancki, D. W., Ma, D. I., Havran, W. L. and Fitch, F. W., Cell surface structures involved in T cell activation. Immunol. Rev. 1984. 81: 65-94.
87. Laugel, B., van den Berg, H. A., Gostick, E., Cole, D. K., Wooldridge, L., Boulter, J., Milicic, A. et al., Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J. Biol. Chem. 2007. 282: 23799-23810.
88. Oh, S., Hodge, J. W., Ahlers, J. D., Burke, D. S., Schlom, J. and Berzofsky, J.A., Selective induction of high avidity CTL by altering the balance of signals from APC. J. Immunol. 2003. 170: 2523-2530.
89. Yang, S., Hodge, J. W., Grosenbach, D. W. and Schlom, J., Vaccines with enhanced costimulation maintain high avidity memory CTL. J. Immunol. 2005. 175: 3715-3723.
90. Markiewicz, M. A., Wise, E. L., Buchwald, Z. S., Cheney, E. E., Hansen, T. H., Suri, A., Cemerski, S. et al., IL-12 enhances CTL synapse formation and induces self-reactivity. J. Immunol. 2009. 182: 1351-1361.
91. Oh, S., Perera, L. P., Burke, D. S., Waldmann, T. A. and Berzofsky, J. A., IL-15/IL-15R alpha-mediated avidity maturation of memory CD8+ T cells. Proc. Natl. Acad. Sci. USA 2004. 101: 15154-15159.
92. Apte, S. H., Baz, A., Groves, P., Kelso, A. and Kienzle, N., Interferon-gamma and interleukin-4 reciprocally regulate CD8 expression in CD8+ T cells. Proc. Natl. Acad. Sci. USA 2008. 105: 17475-17480.
93. Belyakov, I. M., Kuznetsov, V. A., Kelsall, B., Klinman, D., Moniuszko, M., Lemon, M., Markham, P. D. et al., Impact of vaccine-induced mucosal high-avidity CD8+CTLs in delay of AIDS viral dissemination from mucosa. Blood 2006. 107: 3258-3264.
94. Belyakov, I. M., Ahlers, J. D., Nabel, G. J., Moss, B. and Berzofsky, J. A., Generation of functionally active HIV-1 specific CD8+CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization. Virology 2008. 381: 106-115.
95. Betts, M. R., Nason, M. C., West, S. M., De Rosa, S. C., Migueles, S. A., Abraham, J., Lederman, M. M. et al., HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+T cells. Blood 2006. 107: 4781-4789.
96. Critchfield, J. W., Young, D. H., Hayes, T. L., Braun, J. V., Garcia, J. C., Pollard, R. B. and Shacklett, B. L., Magnitude and complexity of rectal mucosa HIV-1-specific CD8+T-cell responses during chronic infection reflect clinical status. PLoS ONE 2008. 3: E3577.
97. Ferre, A. L., Hunt, P. W., Critchfield, J. W., Young, D. H., Morris, M. M., Garcia, J. C., Pollard, R. B. et al., Mucosal immune responses to HIV-1 in elite controllers: A potential correlate of immune control. Blood 2009. 113: 3978-3989.
98. Turk, G., Gherardi, M. M., Laufer, N., Saracco, M., Luzzi, R., Cox, J. H., Cahn, P. and Salomon, H., Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variants. J. Virol. 2008. 82: 2853-2866.
99. Badr, G., Bedard, N., Abdel-Hakeem, M. S., Trautmann, L., Willems, B., Villeneuve, J. P., Haddad, E. K. et al., Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+memory T cells. J. Virol. 2008. 82: 10017-10031.
100. Robinson, T. M., Sidhu, M. K., Pavlakis, G. N., Felber, B. K., Silvera, P., Lewis, M. G., Eldridge, J. et al., Macaques co-immunized with SIVgag/pol-HIVenv and IL-12 plasmid have increased cellular responses. J. Med. Primatol. 2007. 36: 276-284.
101. Liu, J., O'Brien, K. L., Lynch, D.M., Simmons, N. L., La Porte, A., Riggs, A. M., Abbink, P. et al., Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 2009. 457: 87-91.
102. Precopio, M. L., Betts, M. R., Parrino, J., Price, D. A., Gostick, E., Ambrozak, D. R., Asher, T. E. et al., Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J. Exp. Med. 2007. 204: 1405-1416.
103. Liu, J., Yu, Q., Stone, G.W., Yue, F. Y., Ngai, N., Jones, R. B., Kornbluth, R. S. and Ostrowski, M. A., CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals. Vaccine 2008. 26: 4062-4072.
104. Rehr, M., Cahenzli, J., Haas, A., Price, D. A., Gostick, E., Huber, M., Karrer, U. and Oxenius, A., Emergence of polyfunctional CD8+T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy. J. Virol. 2008. 82: 3391-3404.
105. Streeck, H., Brumme, Z. L., Anastario, M., Cohen, K. W., Jolin, J. S., Meier, A., Brumme, C. J. et al., Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. PLoS Med. 2008. 5: E100.
106. Oxenius, A., Price, D. A., Easterbrook, P. J., O'Callaghan, C. A., Kelleher, A. D., Whelan, J. A., Sontag, G. et al., Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+and CD4+T lymphocytes. Proc. Natl. Acad. Sci. USA 2000. 97: 3382-3387.
107. Douek, D. C., Brenchley, J. M., Betts, M. R., Ambrozak, D. R., Hill, B. J., Okamoto, Y., Casazza, J. P. et al., HIV preferentially infects HIV-specific CD4+T cells. Nature 2002. 417: 95-98.
108. Hanon, E., Stinchcombe, J. C., Saito, M., Asquith, B. E., Taylor, G. P., Tanaka, Y., Weber, J. N. et al., Fratricide among CD8(+ T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity 2000. 13: 657-664.
109. Goon, P. K., Igakura, T., Hanon, E., Mosley, A. J., Barfield, A., Barnard, A. L., Kaftantzi, L. et al., Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+T cells: Immunodominance hierarchy and preferential infection with HTLV-I. J. Immunol. 2004. 172: 1735-1743.
110. Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W. et al., PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006. 443: 350-354.
111. Petrovas, C., Casazza, J. P., Brenchley, J. M., Price, D. A., Gostick, E., Adams, W. C., Precopio, M. L. et al., PD-1 is a regulator of virus-specific CD8+T cell survival in HIV infection. J. Exp. Med. 2006. 203: 2281-2292.
112. Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M. R. et al., Upregulation of PD-1 expression on HIV-specific CD8+T cells leads to reversible immune dysfunction. Nat. Med. 2006. 12: 1198-1202.
113. Paiardini, M., Cervasi, B., Albrecht, H., Muthukumar, A., Dunham, R., Gordon, S., Radziewicz, H. et al., Loss of CD127 expression defines an expansion of effector CD8+T cells in HIV-infected individuals. J. Immunol. 2005. 174: 2900-2909.
114. Tilton, J. C., Luskin, M. R., Johnson, A. J., Manion, M., Hallahan, C. W., Metcalf, J. A., McLaughlin, M. et al., Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+T cells are a consequence of antigen load. J. Virol. 2007. 81: 2713-2725.
115. Velu, V., Titanji, K., Zhu, B., Husain, S., Pladevega, A., Lai, L., Vanderford, T. H. et al., Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 2009. 458: 206-210.
116. Rouse, B. T., Sarangi, P. P. and Suvas, S., Regulatory T cells in virus infections. Immunol. Rev. 2006. 212: 272-286.
117. Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J. et al., Foxp3+CD25+CD4+natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 2006. 212: 8-27.
118. Sakaguchi, S. and Powrie, F., Emerging challenges in regulatory T cell function and biology. Science 2007. 317: 627-629.
119. Tran, D. Q., Ramsey, H. and Shevach, E. M., Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007. 110: 2983-2990.
120. Liu, W., Putnam, A. L., Xu-Yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A. et al., CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+T reg cells. J. Exp. Med. 2006. 203: 1701-1711.
121. Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M. et al., Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 2006. 203: 1693-1700.
122. Toulza, F., Heaps, A., Tanaka, Y., Taylor, G. P. and Bangham, C. R., High frequency of CD4+FoxP3+cells in HTLV-1 infection: Inverse correlation with HTLV-1-specific CTL response. Blood 2008. 111: 5047-5053.
123. Hieshima, K., Nagakubo, D., Nakayama, T., Shirakawa, A. K., Jin, Z. and Yoshie, O., Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+T cells. J. Immunol. 2008. 180: 931-939.
124. Vukmanovic-Stejic, M., Zhang, Y., Cook, J. E., Fletcher, J. M., McQuaid, A., Masters, J. E., Rustin, M. H. et al., Human CD4+CD25hi Foxp3+regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Invest. 2006. 116: 2423-2433.
125. Goon, P. K., Hanon, E., Igakura, T., Tanaka, Y., Weber, J. N., Taylor, G. P. and Bangham, C. R., High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Blood 2002. 99: 3335-3341.
126. Oh, U., Grant, C., Griffith, C., Fugo, K., Takenouchi, N. and Jacobson, S., Reduced Foxp3 protein expression is associated with inflammatory disease during human t lymphotropic virus type 1 Infection. J. Infect. Dis. 2006. 193: 1557-1566.
127. Yamano, Y., Takenouchi, N., Li, H. C., Tomaru, U., Yao, K., Grant, C. W., Maric, D. A. and Jacobson, S., Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease. J. Clin. Invest. 2005. 115: 1361-1368.
128. Grant, C., Oh, U., Yao, K., Yamano, Y. and Jacobson, S., Dysregulation of TGF-beta signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease. Blood 2008. 111: 5601-5609.
129. Seddiki, N. and Kelleher, A. D., Regulatory T cells in HIV infection: Who's suppressing what? Curr. HIV/AIDS Rep. 2008. 5: 20-26.
130. Krathwohl, M. D., Schacker, T. W. and Anderson, J. L., Abnormal presence of semimature dendritic cells that induce regulatory T cells in HIV-infected subjects. J. Infect. Dis. 2006. 193: 494-504.
131. Lim, A., Tan, D., Price, P., Kamarulzaman, A., Tan, H. Y., James, I. and French, M. A., Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS 2007. 21: 1525-1534.
132. Montes, M., Lewis, D. E., Sanchez, C., de Castilla, D. L., Graviss, E. A., Seas, C. et al., Foxp3+regulatory T cells in antiretroviral-naive HIV patients. AIDS 2006. 20: 1669-1671.
133. Tsunemi, S., Iwasaki, T., Imado, T., Higasa, S., Kakishita, E., Shirasaka, T. and Sano, H., Relationship of CD4+CD25+regulatory T cells to immune status in HIV-infected patients. AIDS 2005. 19: 879-886.
134. Andersson, J., Boasso, A., Nilsson, J., Zhang, R., Shire, N. J., Lindback, S., Shearer, G. M. and Chougnet, C. A., The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J. Immunol. 2005. 174: 3143-3147.
135. Eggena, M. P., Barugahare, B., Jones, N., Okello, M., Mutalya, S., Kityo, C., Mugyenyi, P. and Cao, H., Depletion of regulatory T cells in HIV infection is associated with immune activation. J. Immunol. 2005. 174: 4407-4414.
136. Boasso, A., Vaccari, M., Hryniewicz, A., Fuchs, D., Nacsa, J., Cecchinato, V., Andersson, J. et al., Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection. J. Virol. 2007. 81: 11593-11603.
137. Estes, J. D., Li, Q., Reynolds, M. R., Wietgrefe, S., Duan, L., Schacker, T., Picker, L. J. et al., Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J. Infect. Dis. 2006. 193: 703-712.
138. Nilsson, J., Boasso, A., Velilla, P. A., Zhang, R., Vaccari, M., Franchini, G., Shearer, G. M. et al., HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 2006. 108: 3808-3817.
139. Carrington, M., Nelson, G. W., Martin, M. P., Kissner, T., Vlahov, D., Goedert, J. J., Kaslow, R. et al., HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999. 283: 1748-1752.
140. Klein, M. R., van der Burg, S. H., Hovenkamp, E., Holwerda, A. M., Drijfhout, J. W., Melief, C. J. and Miedema, F., Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. J. Gen. Virol. 1998. 79: 2191-2201.
141. Migueles, S. A. and Connors, M., Frequency and function of HIV-specific CD8(+) T cells. Immunol. Lett. 2001. 79: 141-150.
142. Migueles, S. A., Sabbaghian, M. S., Shupert, W. L., Bettinotti, M. P., Marincola, F. M., Martino, L., Hallahan, C. W. et al., HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIVinfected long term nonprogressors. Proc. Natl. Acad. Sci. USA 2000. 97: 2709-2714.
143. Miura, T., Brockman, M. A., Schneidewind, A., Lobritz, M., Pereyra, F., Rathod, A., Block, B. L. et al., Hla-B57/B*5801 Hiv-1 elite controllers select for rare Gag variants associated with reduced viral replication capacity and strong ctl recognition. J. Virol. 2009. 83: 2743-2755.
144. Schneidewind, A., Brockman, M. A., Yang, R., Adam, R. I., Li, B., Le Gall, S., Rinaldo, C. R. et al., Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J. Virol. 2007. 81: 12382-12393.
145. Carrington, M., Martin, M. P. and van Bergen, J., KIR-HLA intercourse in HIV disease. Trends Microbiol. 2008. 16: 620-627.
146. Kiepiela, P., Leslie, A. J., Honeyborne, I., Ramduth, D., Thobakgale, C., Chetty, S., Rathnavalu, P. et al., Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004. 432: 769-775.
147. Streeck, H., Schweighardt, B., Jessen, H., Allgaier, R. L., Wrin, T., Stawiski, E. W., Jessen, A. B. et al., Loss of HIV-1-specific T-cell responses associated with very rapid HIV-1 disease progression. AIDS 2007. 21: 889-891.
148. van Baalen, C. A., Guillon, C., van Baalen, M., Verschuren, E. J., Boers, P. H., Osterhaus, A. D. and Gruters, R. A., Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes. Eur. J. Immunol. 2002. 32: 2644-2652.
149. Altfeld, M., Kalife, E. T., Qi, Y., Streeck, H., Lichterfeld, M., Johnston, M. N., Burgett, N. et al., HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8(+) T cell response against HIV-1. PLoS Med. 2006. 3: E403.
150. Hatano, H., Delwart, E. L., Norris, P. J., Lee, T. H., Dunn-Williams, J., Hunt, P. W. et al., Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J. Virol. 2009. 83: 329-335.
151. Mahalanabis, M., Jayaraman, P., Miura, T., Pereyra, F., Chester, E. M., Richardson, B., Walker, B. and Haigwood, N. L., Continuous viral escape and selection by autologous neutralizing antibodies in drugnaive human immunodeficiency virus controllers. J. Virol. 2009. 83: 662-672.
152. Miura, T., Brockman, M. A., Brumme, Z. L., Brumme, C. J., Pereyra, F., Trocha, A., Block, B. L. et al., HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1. J. Virol. 2009. 83: 140-149.
153. Fellay, J., Shianna, K. V., Ge, D., Colombo, S., Ledergerber, B., Weale, M., Zhang, K. et al., A whole-genome association study of major determinants for host control of HIV-1. Science 2007. 317: 944-947.